Skip to main content
Annals of Translational Medicine logoLink to Annals of Translational Medicine
. 2022 Oct;10(20):1149. doi: 10.21037/atm-2022-36

Erratum to clostridium butyricum alleviates dextran sulfate sodium-induced experimental colitis and promotes intestinal lymphatic vessel regeneration in mice

Editorial Office1
PMCID: PMC9652521  PMID: 36388779

This article (1) titled “Clostridium butyricum alleviates dextran sulfate sodium-induced experimental colitis and promotes intestinal lymphatic vessel regeneration in mice” (doi: 10.21037/atm-22-1059), unfortunately contains an error in the funding information. The grant number of Shandong Provincial Key Research and Development Program (No. GG201809230187) should be corrected to Shandong Provincial Key Research and Development Program (No. 2019GSF108188). The corrected funding information is as follows.

Funding: This work was supported by the Major Science and Technology Innovation Project of Shandong Province (No. 2018CXGC1220); Shandong Provincial Key Research and Development Program (No. 2019GSF108188); National Natural Science Foundation of China (No. 81801983); Traditional Chinese Medicine Science and Technology Development Plan of Shandong Province (No. 2019-0377); Qianfoshan Grant (Nos. QYPY2020NSFC1015, QYPY2020NSFC0821).

The authors apologize for the oversight.

Click here to view the updated version of the article.

References

  • 1.Chen X, Ma L, Liu X, et al. Clostridium butyricum alleviates dextran sulfate sodium-induced experimental colitis and promotes intestinal lymphatic vessel regeneration in mice. Ann Transl Med 2022;10:341. 10.21037/atm-22-1059 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of Translational Medicine are provided here courtesy of AME Publications

RESOURCES